Clinical Trials on Benign Prostatic Hypertrophy

Total 8700 results

San Carlo di Nancy Hospital
Elesta S.R.L.

Completed

Transperineal Laser Ablation vs Transurethral Resection for Benign Prostatic Obstruction: A Randomized Clinical Trial

Benign Prostatic Hyperplasia | Benign Prostatic Hypertrophy | Benign Prostatic Hypertrophy With Outflow Obstruction | Prostate Hyperplasia

Italy
Academisch Medisch Centrum - Universiteit van Amsterdam...

Not yet recruiting

Registry: TPLA for LUTS

Lower Urinary Tract Symptoms | Benign Prostate Hyperplasia | Benign Prostatic Hypertrophy With Outflow Obstruction
Chong Kun Dang Pharmaceutical

Recruiting

A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846

Benign Prostate Hypertrophy(BPH)

Korea, Republic of
American Medical Systems

Completed

Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)

Benign Prostatic Hyperplasia | BPH | Benign Prostatic Hypertrophy | Prostate Disease
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-397 in Healthy Male Subjects

Benign Prostatic Hypertrophy (BPH)

Korea, Republic of
Indiana Kidney Stone Institute
Richard Wolf Medical Instruments Corporation (RWMIC)

Completed

Randomized Controlled Trial Comparing Two Different Morcellators for HoLEP Procedures

Benign Prostatic Hypertrophy Requiring Surgical Intervention

United States
Fuzhou General Hospital

Completed

Plasmakinetic Enucleation of the Prostate to Treat Benign Prostatic Hypertrophy Patients With Large Prostate

BPH With Large Prostate

China
Benha University

Completed

Bipolar Needlescopic Enucleation Versus Vapoenucleation of BPH

Prostatic Hyperplasia | Prostatic Hypertrophy, Benign | Prostate Obstruction

Egypt
University Hospital, Bordeaux

Not yet recruiting

Outpatient Holmium LASER Enucleation of the Prostate: Benefit of MOSES(TM) 2.0 Technology (MOSES)

Benign Prostatic Hypertrophy | Holmium Laser Enucleation of the Prostate
Boston Scientific Corporation

Completed

Rezum I Pilot Study for Benign Prostatic Hyperplasia (Rezum Pilot)

Prostatic Hyperplasia | Benign Prostatic Hyperplasia | Prostatic Hyperplasia, Benign | Prostatic Hypertrophy | Prostatic Hypertrophy, Benign | Adenoma, Prostatic | Prostatic Adenoma | Rezum

Dominican Republic, Czechia, Sweden
Boston Scientific Corporation

Completed

Rezum FIM Optimization Study (Rezum FIM)

Benign Prostatic Hyperplasia | Prostatic Hyperplasia, Benign | Prostatic Hypertrophy | Prostatic Hypertrophy, Benign | Adenoma, Prostatic | Prostatic Adenoma | Rezum

Dominican Republic
Robert W. Alexander, MD, FICS
Terry, Glenn C., M.D.

Withdrawn

Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy (SVF-BPN)

Nocturia | BPH | BPH With Urinary Obstruction | Prostatism | Prostate Inflammation

United States
IMBiotechnologies Ltd.

Completed

Safety and Efficacy of OCL 503 in Prostate Artery Embolization

Benign Prostatic Hyperplasia | Benign Prostatic Hypertrophy

Canada
Vantia Ltd

Completed

Dose Response Study of VA106483 in Males With Nocturia and Benign Prostatic Hypertrophy (BPH)

Nocturia | Benign Prostatic Hypertrophy (BPH)

Germany
IRCCS Policlinico S. Matteo

Completed

Clinical Results of Odyliresin (Iresine Celosia) in Symptomatic Benign Prostatic Hyperplasia (Odyliresin)

Benign Prostatic Hyperplasia | Benign Prostatic Hypertrophy With Outflow Obstruction

Italy
Assistance Publique Hopitaux De Marseille

Completed

Prostate Cancer Antigen 3 (PCA-3) Gene Project

Prostate Cancer | Benign Prostatic Hypertrophy

France
University of California, San Francisco

Completed

MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer

Prostate Cancer | Nonmalignant Neoplasm

United States
Centre Hospitalier Universitaire de Nice

Completed

Feasibility Study of Photovaporisation of Prostate With a Limitated Length of Catheterization of 3 Hours (PRECOCE)

Benign Prostatic Hypertrophy

France
Selcuk University

Suspended

Comparison of Different Energy Sources During TUR-P

Benign Prostatic Hypertrophy

Turkey
University Hospital, Tours

Completed

Assessing the Impact of the PVP With Greenlight Laser Using Prostatic MRI and Contrast-enhanced Ultrasound (PROPIL)

Prostatic Hypertrophy, Benign

France
Yonsei University

Completed

The Effects of Intrathecal Dexmedetomidine on Spinal Anesthesia Using Diluted Low-Dose Bupivacaine for Transurethral Resection of Prostate in Elderly

Benign Prostatic Hypertrophy

Korea, Republic of
AEterna Zentaris

Completed

Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH) (AEZS-102-Z041)

Benign Prostatic Hypertrophy

United States, Canada
Bayer

Completed

Vardenafil in Greenlight(TM) Laser Surgery of Benign Prostate Hypertrophy

Prostatic Hypertrophy, Benign

Germany
North Florida/South Georgia Veterans Health System

Completed

Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H)

Benign Prostatic Hypertrophy
Olympus Surgical Technologies Europe

Terminated

Transurethral Vapor Enucleation Resection of the Prostate (TVERP), Bipolar TURis and HoLEP

Benign Prostatic Hypertrophy

China
AEterna Zentaris

Terminated

Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)

Benign Prostatic Hypertrophy

United States, Canada, Bulgaria, Germany
AEterna Zentaris

Completed

Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)

Benign Prostatic Hypertrophy

Netherlands, Belarus, Bulgaria, Czech Republic, France, Germany, Italy, Macedonia, The Former Yugoslav Republic of, Romania, United Kingdom
João Martins Pisco

Completed

Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia

Lower Urinary Tract Symptoms | Prostatic Diseases | Prostatic Hyperplasia, Benign | Prostatic Hypertrophy, Benign | Genital Diseases, Male

Portugal
Spectrum Pharmaceuticals, Inc

Completed

The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the Prostate

Benign Prostatic Hypertrophy

United States
Urotronic Inc.

Active, not recruiting

Optilume™ BPH Prostatic Drug Coated Balloon Dilation Catheter (EVEREST-I)

Benign Prostatic Hyperplasia | Benign Prostatic Hypertrophy

Dominican Republic, Panama
JUNGNAM KWON

Completed

Moxibustion as an Adjuvant for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: a Pilot Study

Benign Prostatic Hyperplasia | Lower Urinary Tract Symptom | BPH | Benign Prostatic Hypertrophy

Korea, Republic of
National Institute of Diabetes and Digestive and...
George Washington University

Completed

Medical Therapy of Prostatic Symptoms (MTOPS)

Prostatic Hyperplasia | Prostatic Hypertrophy, Benign

United States
Prostate Laser Center, PLLC
Medtronic

Completed

MRI Guided Transrectal Prostate Laser Ablation for Benign Prostatic Hypertrophy (BPH)

BPH | Urinary Frequency/Urgency | Prostate Hyperplasia

United States
University Hospitals Cleveland Medical Center
Sanofi

Completed

Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED)

Erectile Dysfunction | BPH

United States
Rhode Island Hospital

Terminated

Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH)

Lower Urinary Tract Symptoms | Benign Prostatic Hypertrophy

United States
University of Magdeburg

Completed

Saline With Alcohol in TransUrethral Resection aNd Photoselective Vaporisation of the Prostate (SATURN-P)

Benign Prostatic Hypertrophy

Germany
JW Pharmaceutical

Completed

Safety and Efficacy of QD Versus BID Silodosin With Lower Urinary Tract Symptoms Suggestive of BPH

Benign Prostatic Hypertrophy

Korea, Republic of
University of Virginia
Siemens Medical Solutions

Unknown

Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia

Prostatic Hyperplasia | Hyperplasia | Male Urogenital Diseases | Prostatic Hypertrophy | Benign Prostatic Hyperplasia (BPH) | Genital Diseases, Male | Lower Urinary Tract Symptoms (LUTS) | Prostatism

United States
Astellas Pharma Inc

Completed

Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia

Overactive Bladder | Benign Prostatic Hyperplasia | Benign Prostatic Hypertrophy

Japan
ClinSearch
Biocompatibles UK Ltd; European Georges Pompidou Hospital

Unknown

Prostate Embolization for Acute Urinary Retention Study (PARIS1)

Prostatic Hypertrophy, Benign

France
Northwestern University

Completed

Wolf 24 F vs. Storz 28 F Laser Sheath Size for HoLEP

Benign Prostatic Hypertrophy

United States
Beth Israel Deaconess Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia | Urinary Obstruction | Prostate Disease | Prostate Hyperplasia | Prostate Hypertrophy | Prostate Pain | Urinary Tract Disease

United States
Sanofi

Completed

Clinical Trial in Males With BPH (Enlarged Prostate)

Prostatic Hyperplasia | Urinary Retention | Benign Prostatic Hypertrophy

United States, Canada, Poland, Romania, Australia, Netherlands, Portugal, Spain, Sweden, Bulgaria, Denmark, Finland, Hungary, Norway, South Africa, Greece, Israel
Samsung Medical Center
GlaxoSmithKline

Completed

Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction

Benign Prostatic Hyperplasia

Korea, Republic of
Astellas Pharma Inc
Astellas Pharma Singapore Pte. Ltd.

Completed

A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)

Overactive Bladder

Japan, Korea, Republic of
VA Office of Research and Development
Merck Sharp & Dohme LLC; Endo Pharmaceuticals

Completed

5-Alpha Reductase and Anabolic Effects of Testosterone

Sarcopenia | Muscle Atrophy | Male Hypogonadism | Benign Prostate Hypertrophy

United States
Intermountain Health Care, Inc.
NuView Diagnostics

Unknown

Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones. (VPAC)

Prostate Cancer | Kidney Stones | Benign Prostatic Hypertrophy | Bladder Stones

United States
Menoufia University

Completed

Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH

Prostatic Neoplasms | Prostate Disease | Prostate Hypertrophy | Prostate Obstruction

Egypt
Gangnam Severance Hospital

Recruiting

Efficacy of α-blocker or 5-ARI Withdrawal to Continued Combination Therapy on the Maintenance of LUTS in Men With BPH

Prostatic Hyperplasia | Prostatic Hypertrophy | Prostate Hyperplasia

Korea, Republic of
GlaxoSmithKline

Completed

Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate Hyperplasia

Benign Prostatic Hyperplasia

Clinical Trials on Benign Prostatic Hypertrophy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations